News and Announcements
Merriman Capital Inc. Establish an Initial Target Price and Report on Alexium International Group Limited
- Published December 12, 2012 6:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Perth, WA and Greer, South Carolina, Alexium International Group Limited (Alexium) (ASX:AJX, AX:AJX, OTC QX:AXXIY) is pleased to inform that Merriman Capital Inc., an investment banking firm and based equity research and corporate advisory firm, with headquarters in San Francisco, has published a report on Alexium International Group Limited.
This is an independent research, which can be found on the Alexium International Website. Merriman Capital Inc. is a market leading in the United States, and Alexium in pleased to receive this initial report from Merriman Capital Inc. Alexium looks forward to working with Merriman in the future. Merriman Capital Inc. has also advised us, that their report has been distributed to their global market base.
———-
To view the full article, please click the link below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
